Original price was: $578.00.$387.00Current price is: $387.00.
Wolverine 2.0 is a premium three-compound research blend formulated with GHK-Cu, BPC-157, and TB-500. Each vial combines 50MG GHK-Cu, 10MG BPC-157, and 10MG TB-500, providing 70MG of total research material.
This combination brings together three distinct research compounds that have been investigated in experimental models involving extracellular-matrix remodeling, cellular signaling, angiogenesis, inflammation, and tissue-repair processes. The available evidence varies substantially between compounds, and much of it remains preclinical rather than established human clinical evidence. PubMed
GHK-Cu (Copper Tripeptide-1) is a naturally occurring copper-binding tripeptide composed of glycine, histidine, and lysine complexed with copper.
GHK-Cu has attracted considerable research interest because of its involvement in biological processes associated with extracellular-matrix remodeling, redox regulation, inflammatory signaling, angiogenesis, and tissue-repair pathways. Researchers have also investigated its interactions with collagen-related processes and cellular responses associated with tissue remodeling. PubMed
In Wolverine 2.0, GHK-Cu represents the largest component of the formulation at 50MG per vial.
BPC-157 is a synthetic 15-amino-acid peptide that has been investigated primarily in laboratory and animal models.
Preclinical research has examined BPC-157 in relation to vascular and endothelial responses, nitric-oxide-associated pathways, oxidative stress, inflammatory signaling, angiogenic signaling, and experimental models of tissue injury and repair. Animal research has also investigated the compound in tendon, ligament, muscle, gastrointestinal, and other tissue models. PubMed
Importantly, BPC-157 remains investigational. Reviews of the evidence note that human clinical research is extremely limited and that there is currently no validated clinical dosing regimen or established human therapeutic use. PubMed
Each Wolverine 2.0 vial contains 10MG BPC-157.
TB-500 is commonly discussed in research in connection with thymosin beta-4 (Tβ4) biology. Thymosin beta-4 is an actin-binding peptide involved in cellular processes such as cell migration and differentiation.
Experimental research on thymosin beta-4 has investigated cell migration, endothelial activity, angiogenesis, inflammatory processes, and tissue-repair mechanisms. Studies have reported effects on endothelial-cell migration, adhesion and blood-vessel formation in experimental systems. PubMed
Because commercial materials described as TB-500 should not automatically be treated as identical to every thymosin beta-4 preparation studied in published research, research findings should be interpreted according to the precise material and experimental model being evaluated.
Each Wolverine 2.0 vial contains 10MG TB-500.
Wolverine 2.0 provides researchers with three compounds in one formulation, making it suitable for experimental investigations where GHK-Cu, BPC-157, and TB-500 are being studied together within the same research framework.
Product Specifications: GHK-Cu 50MG, BPC-157 10MG, TB-500 10MG, for 70MG total material per vial. Supplied as lyophilized research material.
This product is intended strictly for laboratory research and analytical purposes. Not for human or veterinary use. It is not intended to diagnose, treat, cure, mitigate, or prevent any disease. No statements on this page should be interpreted as establishing clinical efficacy or safety.
Wolverine 2.0 — Three research compounds. One premium formulation.
No reviews yet. Be the first to review!
By entering, you accept our Terms and confirm you are of legal age to view research compounds in your jurisdiction.
All compounds are sold for research and laboratory use only. Products are not for human consumption or medical use.
Write a Review